Advertisement
|
June 20, 2012
-
Arthritis Drug Shows Promise for Glucose Control
in Diabetes Patients
The latest potential therapy for lowering glucose in diabetes patients is already sitting on your pharmacy shelves. A new study says salsalate, currently used to treat pain and inflammation in ailments such as rheumatoid arthritis, is effective in controlling blood sugar even when doses of other medications are reduced. What are some of the side-effects that are creating concern?
Read more…
-
Customers Complaining About Low Energy?
Could Be Their Statin
For the 25% of Americans over 45 who take a statin, maybe it’s not just age that’s slowing them down. Lower energy levels and fatigue with exertion appear to occur more often in those who take the cholesterol-lowering drugs compared to those who do not, according to a new study. Which statin had the greatest effect on both decreasing cholesterol levels and energy levels, according to researchers?
Read more…
-
New Toolkit Helps Independent Pharmacies Catch Up With E-Prescribing
Independent pharmacies could find themselves at a competitive disadvantage if they don’t quickly adopt e-prescribing, but more than a quarter have yet to do so. To help with the arduous undertaking, a government agency is offering a toolkit that provides step-by-step guidance on adopting e-prescribing technology. Here’s how to get it.
Read more…
-
Good News and Bad News for Anti-TNF Treatment of Rheumatoid Arthritis
When it comes to a reduction in cardiovascular events in rheumatoid arthritis patients who take antitumor necrosis factor drugs, the silver lining is not without a dark cloud. The drugs also appear to greatly increase the risk of shingles. Find out what new research is saying about the pros and cons of anti-TNF therapy.
Read more…
|